Reuters Genmab and AbbVie's blood cancer drug fails to improve survival in late-stage study
Genmab and AbbVie's blood cancer drug fails to improve survival in late-stage study
Genmab and AbbVie's blood cancer drug fails to improve survival in late-stage study